Huntington Beach, CA3 Active Studies

Pulmonary Embolism Clinical Trials in Huntington Beach, CA

Find 3 actively recruiting pulmonary embolism clinical trials in Huntington Beach, CA. Connect with local research sites and explore new treatment options.

3
Active Trials
3
Sponsors
1,723
Enrolling

Recruiting Pulmonary Embolism Studies in Huntington Beach

About Pulmonary Embolism Clinical Trials in Huntington Beach

Pulmonary embolism (PE) is a blockage of an artery in the lungs, usually caused by blood clots that travel from the deep veins of the legs. It can be life-threatening and requires immediate medical attention. Treatment includes anticoagulants and in severe cases, thrombolytic therapy.

There are currently 3 pulmonary embolism clinical trials recruiting participants in Huntington Beach, CA. These studies are seeking a combined 1,723 participants. Research is being sponsored by Sanofi, Pfizer, Eli Lilly and Company. Clinical trial participation is free and participants receive study-related medical care at no cost.

Pulmonary Embolism Clinical Trials in Huntington Beach — FAQ

Are there pulmonary embolism clinical trials in Huntington Beach?

Yes, there are 3 pulmonary embolism clinical trials currently recruiting in Huntington Beach, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Huntington Beach?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Huntington Beach research site will contact you about next steps.

Are clinical trials in Huntington Beach free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Huntington Beach studies also compensate for your time and travel.

What pulmonary embolism treatments are being tested?

The 3 active trials in Huntington Beach are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary embolism.

Data updated March 2, 2026 from ClinicalTrials.gov